Literature DB >> 25184055

Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning.

Hiroshi Igaki1, Akira Sakumi1, Akitake Mukasa2, Kuniaki Saito2, Akira Kunimatsu1, Yoshitaka Masutani1, Shunya Hanakita2, Kenji Ino1, Akihiro Haga1, Keiichi Nakagawa1, Kuni Ohtomo1.   

Abstract

AIM: To establish intensity-modulated radiotherapy (IMRT) planning procedures that spare the corticospinal tract by integrating diffusion tensor tractography into the treatment planning software.
BACKGROUND: Organs at risk are generally contoured according to the outline of the organ as demonstrated by CT or MRI. But a part of the organ with specific function is difficult to protect, because such functional part of the organ cannot be delineated on CT or conventional sequence of MRI.
METHODS: Diagnostic and treatment planning images of glioblastoma patients who had been treated by conventional 3-dimensional conformal radiotherapy were used for re-planning of IMRT. Three-dimensional fiber maps of the corticospinal tracts were created from the diffusion tensors obtained from the patients before the surgery, and were blended with the anatomical MR images (i.e. gadolinium-enhanced T1-weighted images or T2-weighted images). DICOM-formatted blended images were transferred and fused to the planning CT images. Then, IMRT plans were attempted.
RESULTS: The corticospinal tracts could be contoured as organs at risk (OARs), because the blended images contained both anatomical information and fiber-tract maps. Other OARs were contoured in a way similar to that of ordinary IMRT planning. Gross tumor volumes, clinical target volumes, planning target volumes, and other OARs were contoured on the treatment planning software, and IMRT plans were made.
CONCLUSIONS: IMRT plans with diminished doses to the corticospinal tract were attained. This technique enabled us to spare specific neuron fibers as OARs which were formerly "invisible" and to reduce the probability of late morbidities.

Entities:  

Keywords:  Corticospinal tract; Diffusion tensor tractography; Intensity-modulated radiotherapy; Malignant glioma; Organ at risk

Year:  2014        PMID: 25184055      PMCID: PMC4150090          DOI: 10.1016/j.rpor.2014.01.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  51 in total

1.  Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation.

Authors:  Kyousuke Kamada; Tomoki Todo; Yoshitaka Masutani; Shigeki Aoki; Kenji Ino; Tetsuya Takano; Takaaki Kirino; Nobutaka Kawahara; Akio Morita
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

2.  Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma.

Authors:  Eric L Chang; Serap Akyurek; Tedde Avalos; Neal Rebueno; Chris Spicer; John Garcia; Robin Famiglietti; Pamela K Allen; K S Clifford Chao; Anita Mahajan; Shiao Y Woo; Moshe H Maor
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-15       Impact factor: 7.038

3.  Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas.

Authors:  Mohammad Haris; Shaleen Kumar; Mani Karthick Raj; Koilpillai Joseph Maria Das; Shantanu Sapru; Sanjay Behari; Ram Kishore Singh Rathore; Ponnada A Narayana; Rakesh Kumar Gupta
Journal:  Radiat Med       Date:  2008-04

4.  Hypoxia in radiation-induced blood-spinal cord barrier breakdown.

Authors:  Y Q Li; J R Ballinger; R A Nordal; Z F Su; C S Wong
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

5.  Integration of three-dimensional corticospinal tractography into treatment planning for gamma knife surgery.

Authors:  Keisuke Maruyama; Kyousuke Kamada; Masahiro Shin; Daisuke Itoh; Shigeki Aoki; Yoshitaka Masutani; Masao Tago; Takaaki Kirino
Journal:  J Neurosurg       Date:  2005-04       Impact factor: 5.115

Review 6.  A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy.

Authors:  Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

7.  Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.

Authors:  Nathan S Floyd; Shiao Y Woo; Bin S Teh; Charlotte Prado; Wei-Yuan Mai; Todd Trask; Philip L Gildenberg; Paul Holoye; Mark E Augspurger; L Steven Carpenter; Hsin H Lu; J Kam Chiu; Walter H Grant; E Brian Butler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

8.  Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy.

Authors:  Kiyoshi Nakamatsu; Minoru Suzuki; Yasumasa Nishimura; Shuichi Kanamori; Ryuta Koike; Toru Shibata; Naoya Shintani; Masahiko Okumura; Kaoru Okajima; Fumiharu Akai
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

9.  Resolving crossings in the corticospinal tract by two-tensor streamline tractography: Method and clinical assessment using fMRI.

Authors:  Arish A Qazi; Alireza Radmanesh; Lauren O'Donnell; Gordon Kindlmann; Sharon Peled; Stephen Whalen; Carl-Fredrik Westin; Alexandra J Golby
Journal:  Neuroimage       Date:  2008-07-08       Impact factor: 6.556

Review 10.  Positron emission tomography/computed tomography for target delineation in head and neck cancers.

Authors:  Peter H Ahn; Madhur K Garg
Journal:  Semin Nucl Med       Date:  2008-03       Impact factor: 4.446

View more
  2 in total

1.  Metachronous medulloblastoma and glioblastoma: Implications for clinical and technical aspects of re-irradiation.

Authors:  Vivek Verma; Rajesh R Kulkarni; Abhijeet R Bhirud; Nathan R Bennion; Rodney D McComb; Chi Lin
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-21

Review 2.  Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life.

Authors:  Priyamvada Gupta; Rakesh Jalali
Journal:  Curr Neurol Neurosci Rep       Date:  2017-11-08       Impact factor: 5.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.